This application details a three-year renewal of a K01 International Research Scientist Career Development Award focused on identifying human gene polymorphisms related to Vibrio cholerae infection. The program will be conducted under the collaborative mentorship of Dr. Stephen B. Calderwood, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts and Dr. Firdausi Qadri, Laboratory Sciences Division, International Centre for Diarrhoeal Diseases Research, Dhaka, Bangladesh. The candidate is trained in Infectious Diseases and has a documented commitment to an independent research career in the field of international health. The training program will include courses in human genetics and research ethics. The research component will focus on three specific aims: (1) to characterize the association between susceptibility to Vibrio cholerae infection and variants in candidate human genes related to innate and acquired immunity;(2) to determine the functional consequences of polymorphisms in genes that are found to be associated with susceptibility to Vibrio cholerae infection;and (3) to identify candidate loci for natural selection in the Bangladeshi population. The mentors and supporting faculty will assist with the progress of the applicant's research. The program will allow the candidate to further develop as an independent biomedical researcher focused on global health challenges. Furthermore, data generated with the support of this program will enable the candidate to apply for NIH funding for future studies of human genetic factors associated with cholera and other enteric infections.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
2K01TW007144-05
Application #
7556813
Study Section
Special Emphasis Panel (ZRG1-BDA-K (50))
Program Officer
Jessup, Christine
Project Start
2009-05-15
Project End
2011-08-31
Budget Start
2009-05-15
Budget End
2011-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$131,760
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Khan, Ashraful I; Chowdhury, Fahima; Leung, Daniel T et al. (2015) Cholera in pregnancy: Clinical and immunological aspects. Int J Infect Dis 39:20-4
Falkard, Brie; Uddin, Taher; Rahman, M Arifur et al. (2015) Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh. Am J Trop Med Hyg 93:244-9
Uddin, Taher; Aktar, Amena; Xu, Peng et al. (2014) Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg 90:873-81
Alam, Mohammad Murshid; Bufano, Megan Kelly; Xu, Peng et al. (2014) Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide. PLoS Negl Trop Dis 8:e2683
Bhuiyan, Saruar; Sayeed, Abu; Khanam, Farhana et al. (2014) Cellular and cytokine responses to Salmonella enterica serotype Typhi proteins in patients with typhoid fever in Bangladesh. Am J Trop Med Hyg 90:1024-30
Leung, Daniel T; Uddin, Taher; Xu, Peng et al. (2013) Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol 20:780-8
Rahman, Atiqur; Rashu, Rasheduzzaman; Bhuiyan, Taufiqur Rahman et al. (2013) Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol 20:1592-8
Charles, Richelle C; Sultana, Tania; Alam, Mohammad Murshid et al. (2013) Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal. PLoS Negl Trop Dis 7:e2335
Sealfon, Rachel; Gire, Stephen; Ellis, Crystal et al. (2012) High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic. BMC Genomics 13:468
Tarique, A A; Kalsy, A; Arifuzzaman, M et al. (2012) Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice. Clin Vaccine Immunol 19:594-602

Showing the most recent 10 out of 51 publications